Inmed Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.46

+0.03 (+2.10%)

As of Aug 8, 2:37 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 38%

Sell 5 63%

Price Target

Analyst Price Target +2,204.8% upside

Low Target $24.21

Average Target $33.65

High Target $46.15

Current Price $1.46

Current
$1.46

Target
$33.65

$24.21 $33.65 avg $46.15

Scenario Analysis

Bear Case

$24.21

1,558.2%

Low target

Base Case

$33.65

+2,204.8%

Avg target

Bull Case

$46.15

+3,061.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$2.50

-41.6% from high

52-Week Low

$0.58

+153.9% from low

Target vs 52W High

$33.65

+1,246.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%